Not for human or animal consumption
Primary Metabolic Pathways Beta-3-Adrenergic Receptor Modulation Research in obese mice demonstrated that AOD-9604 increases expression of beta-3-adrenergic receptor RNA in adipose tissue, upregulating levels from those seen in obese animals to levels comparable with lean controls
Because of this targeted structure, it is discussed in research in the context of fat metabolism rather than the broader effects of full growth hormone
The effect was dose-dependent within a specific range, with the most pronounced results between 10 to the negative twelfth and 10 to the negative ninth molar
So the practical takeaway is not oral is better or SC is better. It is: pick one route, follow the documented per-dose figure for the vial you have, and keep the route constant so that whatever you observe is not confounded by a mid-stream route change
Subsequent work by Heffernan and coworkers (2001) confirmed the peptides effects in obese mouse models, with chronic administration associated with reduced body weight gain and decreased adiposity without concurrent changes in food intake